Skip to main content
Year archive

ACTINOGEN MEDICAL LIMITED — 2020 filings

All 50 regulatory filings released by ACTINOGEN MEDICAL LIMITED (ACW) in 2020, sourced directly from the official regulator.

50 Filings
2020 Period
2020 filings (50)
Filing Released Lang
Review of 2020 and outlook 3 pages 186.0KB
Management Reports
2020-12-16 English
AGM Presentations 21 pages 1.6MB
AGM Information
2020-11-26 English
Results of Annual General Meeting 3 pages 225.0KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-26 English
Replacement Constitution 54 pages 327.7KB
Governance Information
2020-11-26 English
Appendix 2A 16 pages 169.8KB
Capital/Financing Update
2020-11-16 English
Appendix 3Y x 4 8 pages 85.9KB
Director's Dealing
2020-11-16 English
Completion of Entitlement Offer 2 pages 206.2KB
Capital/Financing Update
2020-11-12 English
Actinogen files new patent applications 2 pages 207.6KB
Regulatory Filings
2020-11-08 English
Retail Entitlement Offer-Closing Date Reminder 2 pages 169.1KB
Capital/Financing Update
2020-11-04 English
FDA IND Update 2 pages 168.4KB
Regulatory Filings
2020-11-03 English
ACW to initiate XanaFX clinical trial in Fragile X syndrome 17 pages 1.1MB
Investor Presentation
2020-11-01 English
Update to Appendix 3B 51 pages 503.7KB
Capital/Financing Update
2020-10-29 English
Quarterly Activity Report & Appendix 4C 10 pages 292.7KB
Interim / Quarterly Report
2020-10-28 English
R&D Tax Incentive Rebate received of A$2.9 million 2 pages 198.7KB
Capital/Financing Update
2020-10-26 English
Change in substantial holding 4 pages 102.7KB
Major Shareholding Notification
2020-10-25 English
Incorrect BPAY Biller Code provided by share registry 2 pages 169.0KB
Capital/Financing Update
2020-10-25 English
Letter to Shareholders, Notice of AGM & Proxy Form 87 pages 1.8MB
AGM Information
2020-10-25 English
Annual Report to Shareholders 81 pages 1.1MB
Annual Report
2020-10-25 English
Offer Booklet 34 pages 746.3KB
Capital/Financing Update
2020-10-22 English
Letter to Ineligible Shareholders 2 pages 249.9KB
Capital/Financing Update
2020-10-22 English
Correction of Entitlement Offer allotment date 2 pages 166.3KB
Regulatory Filings
2020-10-22 English
Appendix 2A 16 pages 176.6KB
Capital/Financing Update
2020-10-21 English
Cleansing Notice 1 page 277.2KB
Capital/Financing Update
2020-10-21 English
Change to Date of Annual General Meeting 2 pages 167.1KB
AGM Information
2020-10-15 English
ACW announces two clinical trials & launches capital raising 4 pages 232.0KB
Capital/Financing Update
2020-10-14 English
Proposed issue of Securities - ACW 10 pages 40.2KB
Capital/Financing Update
2020-10-14 English
Actinogen Presentation & Planned Conference Call 31 pages 2.7MB
Investor Presentation
2020-10-14 English
Notice under Section 708AA of the Corporations Act 2001 (Cth 2 pages 261.7KB
Capital/Financing Update
2020-10-14 English
Letter to Optionholders re Non-Renounceable Rights Issue 4 pages 375.3KB
Capital/Financing Update
2020-10-14 English
Trading Halt 2 pages 135.6KB
Capital/Financing Update
2020-10-12 English
Appendix 3G 18 pages 247.5KB
Share Issue/Capital Change
2020-10-01 English
Date of AGM & Closing Date for Director Nominations 2 pages 168.2KB
AGM Information
2020-09-28 English
Actinogen Appoints Chief Financial Officer 2 pages 199.7KB
Board/Management Information
2020-09-27 English
Actinogen Medical Investor Presentation 16 pages 1.3MB
Investor Presentation
2020-09-08 English
Appendix 4E & Annual Report 83 pages 1.1MB
Annual Report
2020-08-25 English
Appendix 4G 8 pages 240.9KB
Governance Information
2020-08-25 English
Quarterly Activity Report & Appendix 4C 9 pages 284.3KB
Interim / Quarterly Report
2020-07-28 English
Response to ASX Price Query 6 pages 261.5KB
Regulatory Filings
2020-06-30 English
Market Update and ACW to Participate in BIO Digital 3 pages 213.6KB
Regulatory Filings
2020-06-03 English
Actinogen Presentation at AAT-ADPD International Congress 2 pages 169.1KB
Investor Presentation
2020-04-28 English
Quarterly Activity Report & Appendix 4C 8 pages 239.0KB
Interim / Quarterly Report
2020-04-22 English
Actinogen presents latest Xanamem data at AD Conference 2 pages 242.9KB
Regulatory Filings
2020-03-31 English
Market Update COVID-19 2 pages 167.6KB
Regulatory Filings
2020-03-25 English
Appendix 4D & Half-Year Financial Statements 29 pages 819.5KB
Interim / Quarterly Report
2020-02-19 English
Additional R&D Tax Incentive rebate received 2 pages 160.6KB
Capital/Financing Update
2020-02-16 English
Final share buy-back notice - Appendix 3F 2 pages 292.5KB
Transaction in Own Shares
2020-01-30 English
ASIC Form 484 2 pages 127.6KB
Regulatory Filings
2020-01-30 English
Appendix 3Y-Dr Bill Ketelbey 2 pages 28.7KB
Director's Dealing
2020-01-30 English
December 2019 Quarterly Update 8 pages 372.8KB
Interim / Quarterly Report
2020-01-27 English
Actinogen at SACHS Forum and JP Morgan week 22 pages 2.2MB
Investor Presentation
2020-01-07 English